Editor-in-Chief of Haematologica/Journal of Hematology
Con to the question "Should Performance Enhancing Drugs (Such as Steroids) Be Accepted in Sports?"
"Unfortunately rHuEpo [recombinant human erythropoietin] is intricately intertwined with the endless plague of blood doping in endurance sports. The available information (rumors) indicates that its use is reaching epidemic proportions...
It is unlikely that the objective of deterring blood doping will be achieved if only a few good Samaritans pursue it. We would like to see authorities and pharmaceutical companies themselves more committed to this task."
"Erythropoietin Therapy: Need for Rationality and Active Surveillance," Haematologica, June 6, 2003
Experts Individuals with MDs, JDs, PhDs, or other relevant advanced degrees, heads of professional sports leagues, and US Congress members with significant involvement in, or related to, performance enhancing drugs and sports. [Note: Experts definition varies by site.]
Involvement and Affiliations:
Editor-in-Chief, Haematologica/Journal of Hematology
Associate Professor of Hematology, University of Pavia Medical School, 1984-present
Member, Board of Directors, Societa Italiana di Ematologia Sperimentale [Italian Society of Experimental Hematology] (SIES)
Acting physician, Division of Hematology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Policlinico San Matteo (Pavia, Italy)
Head of the Anemia Unit, Department of Internal Medicine and Medical Therapy, Section of Internal Medicine and Medical Oncology, IRCCS Policlinico San Matteo
Head of the Autologous Stem Cell Transplantation Program, Department of Internal Medicine and Medical Therapy, Section of Internal Medicine and Medical Oncology, IRCCS Policlinico San Matteo
Board Certification, Internal Medicine, University of Pavia Medical School, 1979
Board certification, Hematology, University of Pavia Medical School, 1975
MD, summa cum laude, University of Pavia Medical School, 1972
Cowritten with GJ. Mufti, et. al, "Diagnosis and Classification of Myelodysplastic Syndrome: International Working Group on Morphology of Myelodysplastic Syndrome (IWGM-MDS) Consensus Proposals for the Definition and Enumeration of Myeloblasts and Ring Spideroblasts," Haematologica, Nov. 2008
Cowritten with L. Malcovati, "Prognostic Relevance of Anemia in Myelodysplastic Syndromes," American Journal of Hematology, Oct. 2008
Cowritten with MA. Melis, et. al, "A Mutation in the TMPRSS6 Gene, Encoding a Transmembrane Serine Protease that Suppresses Hepcidin Producation in Family Iron Deficiency Anemia Refractory to Oral Iron," Haematologica, Oct. 2008
"Can EPO Reduce Blood Transfusion Requirements During Induction Therapy for High-Risk Neuroblastoma?" Nature Clinical Practice Oncology, July 2004
"Once-Weekly Epoetin Beta Is Highly Effective in Treating Anaemic Patients with Lymphoproliferative Malignancy and Defective Endogenous Erythropoietin Production," British Journal of Haematology, Mar. 2004
"Genetic Hyperferritinaemia and Reticuloendothelial Iron Overload Associated with a Three Base Pair Deletion in the Coding Region of the Ferroportin Gene (SLC11A3)," British Journal of Haematology, Nov. 2002